Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

t there were `significant and important failings' in the bureau's repeated pursuit of surveillance authority to track former Trump campaign adviser Carter Page, as part of the investigation." The Washington Times <https://www.washingtontimes.com/news/2020/sep/30/james-comey-i-am-responsible-embarrassing-car

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

t there were 'significant and important failings' in the bureau's repeated pursuit of surveillance authority to track former Trump campaign adviser Carter Page, as part of the investigation." The Washington Times (9/30, Mordock, 492K) says Comey "took responsibility for what he described as 'embarrassing' e

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

imes (9/30, Mordock, 492K) reports that Comey "admitted...that he wouldn't have signed the warrant application to wiretap former Trump campaign aide Carter Page. `No. Not without a much fuller discussion about how they were thinking about their obligations to the court,' Mr. Comey said in testimony before th

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

imes (9/30, Mordock, 492K) reports that Comey "admitted...that he wouldn't have signed the warrant application to wiretap former Trump campaign aide Carter Page. 'No. Not without a much fuller discussion about how they were thinking about their obligations to the court,' Mr. Comey said in testimony before th